Park Medi World Share Seen with Potential for Additional 20% Gain Despite 90% Year-to-Date Performance.

Park Medi World Expects 20% Upside as Brokerage Firm Maintains 'Buy' Rating

Choice Broking, a leading brokerage firm, has released a report stating that it expects a 20% upside in the healthcare stock Park Medi World. The firm has maintained a 'buy' rating for the stock with a revised target price of ₹350 apiece.

The management of Park Medi World expects the company's growth to be driven by aggressive capacity expansion, efficient capital deployment, a richer case mix, optimized average length of stay (ALOS), improved payor mix, and revised Central Government Health Scheme (CGHS) rate benefits. The management has revealed that by the second year, revenues are expected to scale up to ₹1,400 million, with earnings before interest, taxes, depreciation, and amortization (EBITDA) improving to ₹35 million and profit after tax (PAT) of ₹21 million.

The firm's confidence in Park Medi World is supported by strong promoter commitment, a healthy financial position, proven execution capability, and access to capital. The company turned debt-free in February 2026 and continues to generate healthy operating cash flows, providing financial flexibility for expansion.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Park Medi World reported a strong set of numbers for Q4 FY26 on Tuesday, 12 May, with consolidated net profit attributable to owners of the company rising 58% year-on-year to ₹70.9 crore. The company's consolidated net profit after tax rose 47% year-on-year to ₹76.8 crore. Revenue from operations grew 30% YoY to ₹460.4 crore, up from ₹353.9 crore. At the operating level, EBITDA increased 44% YoY to ₹127.4 crore, while margins expanded to 27.7% from 25.0%, indicating better cost efficiencies and operating leverage.

The company witnessed significant growth during the year, achieving a 20% boost in capacity by adding 610 beds. This was facilitated by acquisitions in Bhatinda (250 beds) and Agra (360 beds), bringing the total capacity to 3,610 beds as of 31 March 2026.

On Wednesday, the healthcare stock was trading marginally lower at ₹285.19 apiece on NSE. The share price trend of the newly-listed stock has remained positive by delivering almost multibagger returns of 90% on a year-to-date (YTD) basis. The healthcare stock has surged 11% in a week and 20.50% in a month. Park Medi World share price, which made its debut at ₹158.80 apiece in December 2025, is currently trading almost 80% above the listing price.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data